Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4 mg/ml - HSA Drug Approval Details

Approvals/HSA/DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4 mg/ml

Approved

STANDARD

DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4 mg/ml

Unknown🇸🇬 Health Sciences Authority

Approval Date: Jan 13, 2026
Approval ID: b6af3db6db55db38
Company: Unknown
Type: Standard

Approval Details

Approval Id: b6af3db6db55db38
Drug Name: DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4 mg/ml

Active Ingredients

DEXAMETHASONE SODIUM PHOSPHATE EQV TO DEXAMETHASONE PHOSPHATE

4mg/mL

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 13, 2026

Approval ID

b6af3db6db55db38

Type

Standard

Back to HSA Approvals